NO991301D0 - FremgangsmÕte for fremstilling av ekteinaskidinforbindelser - Google Patents

FremgangsmÕte for fremstilling av ekteinaskidinforbindelser

Info

Publication number
NO991301D0
NO991301D0 NO991301A NO991301A NO991301D0 NO 991301 D0 NO991301 D0 NO 991301D0 NO 991301 A NO991301 A NO 991301A NO 991301 A NO991301 A NO 991301A NO 991301 D0 NO991301 D0 NO 991301D0
Authority
NO
Norway
Prior art keywords
ecteinascidin
compounds
formation
ecteinascidin compounds
preparation
Prior art date
Application number
NO991301A
Other languages
English (en)
Other versions
NO991301L (no
NO325345B1 (no
Inventor
Elias J Corey
David Gin
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of NO991301D0 publication Critical patent/NO991301D0/no
Publication of NO991301L publication Critical patent/NO991301L/no
Publication of NO325345B1 publication Critical patent/NO325345B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO19991301A 1996-09-18 1999-03-17 Fremgangsmate for fremstilling av ecteinascidin 770 og ecteinascidin 743, mellomprodukter for anvendelse ved fremgangsmaten, samt fremgangsmate for fremstilling av mellomproduktene NO325345B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/715,541 US5721362A (en) 1996-09-18 1996-09-18 Process for producing ecteinascidin compounds
PCT/US1997/016470 WO1998012198A1 (en) 1996-09-18 1997-09-17 Process for producing ecteinascidin compounds

Publications (3)

Publication Number Publication Date
NO991301D0 true NO991301D0 (no) 1999-03-17
NO991301L NO991301L (no) 1999-05-14
NO325345B1 NO325345B1 (no) 2008-04-07

Family

ID=24874473

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991301A NO325345B1 (no) 1996-09-18 1999-03-17 Fremgangsmate for fremstilling av ecteinascidin 770 og ecteinascidin 743, mellomprodukter for anvendelse ved fremgangsmaten, samt fremgangsmate for fremstilling av mellomproduktene

Country Status (21)

Country Link
US (1) US5721362A (no)
EP (1) EP0931083B1 (no)
JP (1) JP4425995B2 (no)
KR (1) KR100358832B1 (no)
CN (1) CN1096463C (no)
AT (1) ATE232868T1 (no)
AU (1) AU738282B2 (no)
BR (1) BR9712073B1 (no)
CA (1) CA2266081C (no)
CZ (1) CZ299596B6 (no)
DE (1) DE69719201T2 (no)
DK (1) DK0931083T3 (no)
ES (1) ES2192273T3 (no)
HU (1) HU229407B1 (no)
IL (2) IL128993A0 (no)
NO (1) NO325345B1 (no)
NZ (1) NZ334704A (no)
PL (1) PL188572B1 (no)
PT (1) PT931083E (no)
RU (1) RU2194709C2 (no)
WO (1) WO1998012198A1 (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL138856A0 (en) * 1998-04-06 2001-10-31 Univ Illinois Semi-synthetic ecteinascidins
US6316214B1 (en) * 1998-05-11 2001-11-13 The Board Of Trustees Of The University Of Illinois ETM-775 metabolite of ecteinascidin 743
US6124292A (en) * 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
GB9918178D0 (en) * 2000-05-15 1999-10-06 Pharma Mar Sa Synthetic methods
BG65893B1 (bg) * 1999-05-14 2010-04-30 Pharma Mar S.A. Полусинтетичен метод и нови съединения
MY130271A (en) * 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
AU783562B2 (en) * 2000-01-19 2005-11-10 Trustees Of Columbia University In The City Of New York, The Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
US6815544B2 (en) 2000-02-11 2004-11-09 President And Fellows Of Harvard College Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds
CZ300326B6 (cs) * 2000-02-11 2009-04-22 President And Fellows Of Harvard College Zpusob syntézy meziproduktu pro ekteinascidin a ftalascidin
US6569859B1 (en) 2000-02-22 2003-05-27 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
PT1280809E (pt) * 2000-04-12 2005-11-30 Pharma Mar Sa Derivados antitumorais de ecteinascidina
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
US7420051B2 (en) * 2000-05-15 2008-09-02 Pharma Mar, S.A. Synthetic process for the manufacture of an ecteinaschidin compound
JP4942900B2 (ja) * 2000-05-15 2012-05-30 ファルマ・マール・ソシエダード・アノニマ エクチナサイジン化合物の製造のための合成方法
CA2447553A1 (en) 2000-11-03 2002-05-23 President And Fellows Of Harvard College Saframycins, analogues and uses thereof
CN100374162C (zh) * 2000-11-06 2008-03-12 法马马有限公司 海鞘素－743在制备用于治疗肿瘤的药剂中的应用
GB0117402D0 (en) * 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) * 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
JP4208469B2 (ja) * 2002-01-29 2009-01-14 独立行政法人科学技術振興機構 エクテナサイジン類の全合成方法、エクテナサイジン類に類縁構造を持つ前記全合成用中間体化合物類、及び該中間体化合物類の合成方法
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
US7183054B2 (en) 2003-06-03 2007-02-27 President And Fellows Of Harvard College Assay for identifying biological targets of polynucleotide-binding compounds
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
DE602004016376D1 (de) * 2003-11-13 2008-10-16 Pharma Mar Sau Kombination von et-743 mit 5-fluorouracil pro-drugs zur behandlung von krebs
WO2005049030A1 (en) * 2003-11-14 2005-06-02 Pharma Mar, S.A. Combination therapy comprising the use of et-743 and paclitaxel for treating cancer
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
EP1768671A2 (en) * 2004-07-09 2007-04-04 Pharma Mar, S.A. Use of ecteinascidin in the treatment of cancer in patients with low level of brca1
CN100396178C (zh) * 2004-08-06 2008-06-25 中国科学院海洋研究所 一种玻璃海鞘的全人工养殖方法及简易型连续投饵装置
WO2006035244A2 (en) * 2004-09-29 2006-04-06 Pharma Mar S.A., Sociedad Unipersonal Ecteinascidin compounds as anti -inflammatory agents
SI1827500T1 (sl) * 2004-10-26 2009-10-31 Pharma Mar Sa Pegiliran liposomski doksorubicin v kombinaciji s ekteinescidinom 743
DK1658848T3 (da) 2004-10-29 2007-11-26 Pharma Mar Sa Formuleringer omfattende ecteinascidin og et disaccharid
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
CN101157929B (zh) * 2007-02-02 2012-05-23 中国科学院上海有机化学研究所 番红霉素的生物合成基因簇
JP2011500046A (ja) * 2007-10-19 2011-01-06 ファルマ・マール・ソシエダード・アノニマ Ｅｔ−７４３治療のための予後分子マーカー
WO2011147828A1 (en) 2010-05-25 2011-12-01 Pharma Mar, S.A. Synthetic process for the manufacture of ecteinascidin compounds
KR20170096065A (ko) 2010-11-12 2017-08-23 파르마 마르 에스.에이. 항종양 알칼로이드를 이용한 병용요법
CN103304478B (zh) * 2013-06-28 2016-04-20 四川大学 一类合成renieramycins型生物碱的中间体及其制备方法
CN104557850B (zh) * 2013-10-29 2019-07-30 江苏盛迪医药有限公司 一种海鞘碱-743中间体的制备方法
CN103709101B (zh) * 2013-12-19 2016-06-29 四川大学 一类renieramycin G的合成中间体及其制备方法
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN111518110B (zh) * 2019-02-01 2023-11-03 博瑞生物医药（苏州）股份有限公司 一种海鞘素化合物及其中间体的制备方法
CN110092802B (zh) * 2019-06-21 2022-01-07 爱斯特（成都）生物制药股份有限公司 一种制备曲贝替定中间体的方法
WO2020261301A1 (en) * 2019-06-27 2020-12-30 Msn Laboratories Private Limited, R&D Center IMPROVED PROCESS FOR THE PREPARATON OF PURE (1'R,6R,6aR,7R,13S,14S,16R)-5-(ACETYLOXY)-3',4',6,6a,7,13,14,16-OCTAHYDRO-6',8,14-TRIHYDROXY-7',9-DIMETHOXY-4,10,23-TRIMETHYLSPIRO[6,16-(EPITHIOPROPANOXYMETH ANO)-7,13-IMINO-12H-1,3-DIOXOLO[7,8]ISOQUINO[3,2-b][3]BENZAZOCINE-20,1'(2'H)-ISOQUINOLIN]-19-ONE POLYMORPH THERE OF
CN114621245A (zh) * 2020-12-11 2022-06-14 江苏恒瑞医药股份有限公司 一种曲贝替定中间体的晶型及其制备方法
US20230226051A1 (en) 2022-01-20 2023-07-20 Extrovis Ag Trabectedin composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149804A (en) * 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
US5256663A (en) * 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5089273A (en) * 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
DE3923985C1 (no) * 1989-07-20 1990-06-28 Daimler-Benz Aktiengesellschaft, 7000 Stuttgart, De
GB2252781B (en) * 1991-02-14 1994-08-17 Sanwa Shutter Corp Architectural shutter curtain device
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins

Also Published As

Publication number Publication date
AU4420597A (en) 1998-04-14
BR9712073B1 (pt) 2013-06-18
HUP0000068A3 (en) 2001-12-28
PL188572B1 (pl) 2005-02-28
PL332206A1 (en) 1999-08-30
CN1237974A (zh) 1999-12-08
JP4425995B2 (ja) 2010-03-03
CN1096463C (zh) 2002-12-18
BR9712073A (pt) 2002-01-15
NO991301L (no) 1999-05-14
AU738282B2 (en) 2001-09-13
EP0931083A1 (en) 1999-07-28
DK0931083T3 (da) 2003-05-26
IL128993A0 (en) 2000-02-17
US5721362A (en) 1998-02-24
EP0931083A4 (en) 2000-05-24
DE69719201T2 (de) 2003-12-11
PT931083E (pt) 2003-07-31
KR100358832B1 (ko) 2002-11-21
CA2266081C (en) 2006-12-12
CZ299596B6 (cs) 2008-09-17
JP2001501196A (ja) 2001-01-30
ES2192273T3 (es) 2003-10-01
CA2266081A1 (en) 1998-03-26
CZ91499A3 (cs) 1999-08-11
ATE232868T1 (de) 2003-03-15
WO1998012198A1 (en) 1998-03-26
NO325345B1 (no) 2008-04-07
NZ334704A (en) 2000-09-29
KR20000036242A (ko) 2000-06-26
DE69719201D1 (de) 2003-03-27
RU2194709C2 (ru) 2002-12-20
HUP0000068A2 (hu) 2000-06-28
IL128993A (en) 2006-06-11
HU229407B1 (en) 2013-12-30
EP0931083B1 (en) 2003-02-19

Similar Documents

Publication Publication Date Title
NO991301D0 (no) FremgangsmÕte for fremstilling av ekteinaskidinforbindelser
MY121760A (en) Benzothiazin and benzoxazin derivatives;their preparation and uses
HUP9701048A2 (hu) Új eljárás sildenafil előállítására és a felhasznált új köztitermékek
NO178764C (no) Fremgangsmåte ved fremstilling av oksetanoner
IL135536A0 (en) Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same
NZ504106A (en) Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them
DK0579770T3 (da) Makrocycliske lactamprokinetika
TR200103848T2 (tr) İkame edilmiş bisiklik heterosikller, bunların hazırlanması için işlem ve antiobesite için ve hipokolesterolemik maddeler olarak kullanımları.
NZ331875A (en) Asymmetric synthesis of R-alpha-propyl-piperonyl amine and its analogs
AU1198897A (en) 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
UA72883C2 (uk) Біциклічна сполука, способи її одержання, фармацевтичні композиції, що її містять,способи лікування та попередження різних захворювань, проміжні сполуки та способи їх одержання
IL160820A0 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
GR3030506T3 (en) 1-azaadamantane derivatives as 5-ht agonists or antagonists.
FR2778404B1 (fr) Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant
SE9800865D0 (sv) New Process
AU7109798A (en) Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypol ipidemia and antihypertensive properties
NO20023769D0 (no) Syntetisk fremgangsmåte for fremstilling av et mellomprodukt for ekteinaskidin- og ftalaskidinforbindelser
MY110494A (en) Benzopyrans
DE3461281D1 (en) +/- 2-((3,4-methylenedioxy)phenethyl)-5-((3-carboxamido-4-hydroxy)-alpha-hydroxybenzyl)pyrrolidines, pharmaceutical compositions containing them, process for their production and intermediates therefor
ES8604210A1 (es) Procedimiento para preparar 2- (fenetil) -5- (3,4-metilen- dioxi)-x-hidroxibencil) -pirrolidina
EP1049481A4 (en) SYNTHETIC ANTINEOPLASTIC ACTIVE SUBSTANCES, DERIVATIVES OF DOLASTATIN 15 AND METHODS OF THEIR PRODUCTION
ES8600760A1 (es) Procedimiento para preparar 2-((3, 4-metilendioxi)-fenetil)-5-((3-carboxamido-4-hidroxi)- -hidroxibencil)-pirrolidina
ATE223417T1 (de) Wasserlösliche c-ring analoge des 20(s)- camphothecins
ES2103237A1 (es) Nuevo compuesto derivado del cromeno

Legal Events

Date Code Title Description
MK1K Patent expired